Kathleen Mulligan

17.8k total citations
148 papers, 8.7k citations indexed

About

Kathleen Mulligan is a scholar working on Emergency Medicine, Infectious Diseases and Physiology. According to data from OpenAlex, Kathleen Mulligan has authored 148 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Emergency Medicine, 56 papers in Infectious Diseases and 37 papers in Physiology. Recurrent topics in Kathleen Mulligan's work include HIV-related health complications and treatments (82 papers), HIV/AIDS drug development and treatment (40 papers) and HIV Research and Treatment (34 papers). Kathleen Mulligan is often cited by papers focused on HIV-related health complications and treatments (82 papers), HIV/AIDS drug development and treatment (40 papers) and HIV Research and Treatment (34 papers). Kathleen Mulligan collaborates with scholars based in United States, Canada and Brazil. Kathleen Mulligan's co-authors include Morris Schambelan, Carl Grünfeld, Joan C. Lo, Viva Tai, Jean‐Marc Schwarz, Heather A. Algren, Steven Grinspoon, Kirsten L. Johansen, Mustafa A. Noor and Michael Wen and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Kathleen Mulligan

144 papers receiving 8.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen Mulligan United States	50	4.1k	3.6k	2.4k	1.8k	1.7k	148	8.7k
Todd T. Brown United States	53	7.6k 1.9×	4.3k 1.2×	3.0k 1.2×	1.3k 0.7×	1.5k 0.9×	354	11.4k
Katherine Samaras Australia	47	4.6k 1.1×	3.7k 1.0×	3.0k 1.2×	1.7k 0.9×	1.5k 0.9×	132	10.3k
Fred R. Sattler United States	44	827 0.2×	2.0k 0.6×	906 0.4×	737 0.4×	1.9k 1.2×	122	5.4k
Samir K. Gupta United States	37	1.7k 0.4×	2.3k 0.6×	909 0.4×	306 0.2×	1.6k 0.9×	186	5.5k
Kristine M. Erlandson United States	37	2.9k 0.7×	1.8k 0.5×	957 0.4×	1.1k 0.6×	698 0.4×	190	4.1k
David Nolan Australia	41	1.5k 0.4×	2.1k 0.6×	1.9k 0.8×	675 0.4×	940 0.6×	149	7.3k
Donald I. Abrams United States	49	966 0.2×	2.8k 0.8×	2.2k 0.9×	735 0.4×	1.7k 1.0×	178	9.1k
Robert C. Kaplan United States	36	1.0k 0.2×	482 0.1×	474 0.2×	841 0.5×	608 0.4×	131	4.4k
Eric C. Seaberg United States	45	832 0.2×	1.6k 0.5×	747 0.3×	288 0.2×	3.5k 2.1×	125	7.3k
Sean X. Leng United States	39	498 0.1×	636 0.2×	223 0.1×	2.5k 1.4×	1.1k 0.7×	113	6.2k

Countries citing papers authored by Kathleen Mulligan

Since Specialization

Citations

This map shows the geographic impact of Kathleen Mulligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Mulligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Mulligan more than expected).

Fields of papers citing papers by Kathleen Mulligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Mulligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Mulligan. The network helps show where Kathleen Mulligan may publish in the future.

Co-authorship network of co-authors of Kathleen Mulligan

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Mulligan. A scholar is included among the top collaborators of Kathleen Mulligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Mulligan. Kathleen Mulligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mulligan, Kathleen, et al.. (2024). The Utility of Sentinel Lymph Node Biopsy in Elderly Patients with Melanoma. Annals of Surgical Oncology. 31(12). 8230–8239. 1 indexed citations

Marin, Benjamin Gallo, Kathleen Mulligan, & Leslie Robinson‐Bostom. (2022). Evaluation of reading level of online patient education materials discussing dermatologic care for patients undergoing dialysis. JAAD International. 8. 58–59. 1 indexed citations

Marin, Benjamin Gallo, et al.. (2022). An Analysis of Information Sources of YouTube Videos Pertaining to Tattoo Removal: Cross-sectional Study. JMIR Dermatology. 5(4). e42759–e42759. 2 indexed citations

Brooks, Kristina M., Jennifer Brothers, Kathleen Mulligan, et al.. (2022). Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate. AIDS Research and Human Retroviruses. 38(12). 939–943. 9 indexed citations

Brooks, Kristina M., Jennifer Brothers, Kathleen Mulligan, et al.. (2022). Pharmacokinetics of Emtricitabine/Tenofovir Disoproxil Fumarate Among Transgender Adolescents and Young Adults Without HIV Receiving Gender Affirming Hormones. AIDS Research and Human Retroviruses. 38(11). 840–846. 7 indexed citations

Zheng, David X., Kathleen Mulligan, Benjamin Gallo Marin, et al.. (2022). Delayed medical care due to transportation barriers among US children with atopic dermatitis. Pediatric Dermatology. 39(6). 927–930. 2 indexed citations

Soldozy, Sauson, Kathleen Mulligan, David X. Zheng, et al.. (2021). Oncolytic Virotherapy for Melanoma Brain Metastases, a Potential New Treatment Paradigm?. Brain Sciences. 11(10). 1260–1260. 9 indexed citations

Sun, Xiaoying, Sheldon Morris, Stan G. Louie, et al.. (2019). Effect of Vitamin D Supplementation on Bone Turnover Markers During HIV Pre-Exposure Prophylaxis Using Tenofovir Disoproxil Fumarate-Emtricitabine in Men Who Have Sex with Men. AIDS Research and Human Retroviruses. 35(7). 608–614. 4 indexed citations

Havens, Peter L., Ashutosh Tamhane, Charles B. Stephensen, et al.. (2018). Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis. AIDS Research and Human Retroviruses. 35(2). 123–128. 6 indexed citations

10.

Havens, Peter L., Marta D. Van Loan, G Schuster, et al.. (2017). Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults with HIV Infection Being Treated with Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial. Clinical Infectious Diseases. 1 indexed citations

11.

Unemori, Patrick, et al.. (2013). Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy. Dermatology Research and Practice. 2013. 1–3. 3 indexed citations

12.

Kendler, David L., João Borges, Roger A. Fielding, et al.. (2013). The Official Positions of the International Society for Clinical Densitometry: Indications of Use and Reporting of DXA for Body Composition. Journal of Clinical Densitometry. 16(4). 496–507. 78 indexed citations

13.

Li, Xiaojuan, Jack Youngren, Giorgos K. Sakkas, et al.. (2007). Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T. Magnetic Resonance Imaging. 26(2). 188–197. 25 indexed citations

14.

Sakkas, Giorgos K., Kathleen Mulligan, Julie Doyle, et al.. (2005). Creatine supplementation fails to augment the benefits derived from resistance exercise training in patients with HIV infection. Antiviral Therapy. 10(8). 1 indexed citations

15.

Schwarz, Jean‐Marc, Kathleen Mulligan, Jeongae Lee, et al.. (2002). Effects of Recombinant Human Growth Hormone on Hepatic Lipid and Carbohydrate Metabolism in HIV-Infected Patients with Fat Accumulation. The Journal of Clinical Endocrinology & Metabolism. 87(2). 942–945. 75 indexed citations

16.

Kaplan, Gilla, Steve D. Thomas, Daniel S. Fierer, et al.. (2000). Thalidomide for the Treatment of AIDS-Associated Wasting. AIDS Research and Human Retroviruses. 16(14). 1345–1355. 67 indexed citations

17.

Lo, Joan C., Kathleen Mulligan, Viva Tai, Heather A. Algren, & Morris Schambelan. (1998). “Buffalo hump” in men with HIV-1 infection. The Lancet. 351(9106). 867–870. 426 indexed citations

18.

Griffin, George E., Nicholas I. Paton, Kamyar Arasteh, et al.. (1998). 2nd Workshop on Nutrition and Quality of Life in HIV Infection: The Role of Growth Hormone in HIV-associated Wasting, Berlin, Germany, 6-7 March, 1998. 1. 199–218. 1 indexed citations

19.

Schambelan, Morris, Kathleen Mulligan, Carl Grünfeld, et al.. (1996). Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting. Annals of Internal Medicine. 74 indexed citations

20.

Fujisawa, Tomotsumi, Kathleen Mulligan, Leslie Wada, et al.. (1993). The effect of exercise on fructose absorption. American Journal of Clinical Nutrition. 58(1). 75–79. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact